BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1008 related articles for article (PubMed ID: 26755942)

  • 1. Global and regional estimates of COPD prevalence: Systematic review and meta-analysis.
    Adeloye D; Chua S; Lee C; Basquill C; Papana A; Theodoratou E; Nair H; Gasevic D; Sridhar D; Campbell H; Chan KY; Sheikh A; Rudan I;
    J Glob Health; 2015 Dec; 5(2):020415. PubMed ID: 26755942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An estimate of the prevalence of COPD in Africa: a systematic analysis.
    Adeloye D; Basquill C; Papana A; Chan KY; Rudan I; Campbell H
    COPD; 2015 Feb; 12(1):71-81. PubMed ID: 24946179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis.
    Adeloye D; Song P; Zhu Y; Campbell H; Sheikh A; Rudan I;
    Lancet Respir Med; 2022 May; 10(5):447-458. PubMed ID: 35279265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the global prevalence of chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis.
    Al Wachami N; Guennouni M; Iderdar Y; Boumendil K; Arraji M; Mourajid Y; Bouchachi FZ; Barkaoui M; Louerdi ML; Hilali A; Chahboune M
    BMC Public Health; 2024 Jan; 24(1):297. PubMed ID: 38273271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global prevalence of chronic obstructive pulmonary disease: systematic review and meta-analysis.
    Varmaghani M; Dehghani M; Heidari E; Sharifi F; Moghaddam SS; Farzadfar F
    East Mediterr Health J; 2019 Mar; 25(1):47-57. PubMed ID: 30919925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An estimate of asthma prevalence in Africa: a systematic analysis.
    Adeloye D; Chan KY; Rudan I; Campbell H
    Croat Med J; 2013 Dec; 54(6):519-31. PubMed ID: 24382846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD Chronic Respiratory Disease Collaborators
    Lancet Respir Med; 2020 Jun; 8(6):585-596. PubMed ID: 32526187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender-specific estimates of COPD prevalence: a systematic review and meta-analysis.
    Ntritsos G; Franek J; Belbasis L; Christou MA; Markozannes G; Altman P; Fogel R; Sayre T; Ntzani EE; Evangelou E
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1507-1514. PubMed ID: 29785100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and correlates of chronic obstructive pulmonary disease and chronic respiratory symptoms in rural southwestern Uganda: a cross-sectional, population-based study.
    North CM; Kakuhikire B; Vořechovská D; Hausammann-Kigozi S; McDonough AQ; Downey J; Christiani DC; Tsai AC; Siedner MJ
    J Glob Health; 2019 Jun; 9(1):010434. PubMed ID: 31217961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of chronic obstructive pulmonary disease (COPD) in China in 1990 and 2010.
    Chan KY; Li X; Chen W; Song P; Wong NWK; Poon AN; Jian W; Soyiri IN; Cousens S; Adeloye D; Sheikh A; Campbell H; Rudan I;
    J Glob Health; 2017 Dec; 7(2):020704. PubMed ID: 29423187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modelling study.
    Song P; Fang Z; Wang H; Cai Y; Rahimi K; Zhu Y; Fowkes FGR; Fowkes FJI; Rudan I
    Lancet Glob Health; 2020 May; 8(5):e721-e729. PubMed ID: 32353319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalences and levels of occupational exposure to dusts and/or fibres (silica, asbestos and coal): A systematic review and meta-analysis from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury.
    Schlünssen V; Mandrioli D; Pega F; Momen NC; Ádám B; Chen W; Cohen RA; Godderis L; Göen T; Hadkhale K; Kunpuek W; Lou J; Mandic-Rajcevic S; Masci F; Nemery B; Popa M; Rajatanavin N; Sgargi D; Siriruttanapruk S; Sun X; Suphanchaimat R; Thammawijaya P; Ujita Y; van der Mierden S; Vangelova K; Ye M; Zungu M; Scheepers PTJ
    Environ Int; 2023 Aug; 178():107980. PubMed ID: 37487377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global, regional, and national prevalence of asthma in 2019: a systematic analysis and modelling study.
    Song P; Adeloye D; Salim H; Dos Santos JP; Campbell H; Sheikh A; Rudan I
    J Glob Health; 2022 Jun; 12():04052. PubMed ID: 35765786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The burden of chronic respiratory diseases and their heterogeneity across the states of India: the Global Burden of Disease Study 1990-2016.
    India State-Level Disease Burden Initiative CRD Collaborators
    Lancet Glob Health; 2018 Dec; 6(12):e1363-e1374. PubMed ID: 30219316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis.
    Song P; Rudan D; Zhu Y; Fowkes FJI; Rahimi K; Fowkes FGR; Rudan I
    Lancet Glob Health; 2019 Aug; 7(8):e1020-e1030. PubMed ID: 31303293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global Burden of Chronic Obstructive Pulmonary Disease Through 2050.
    Boers E; Barrett M; Su JG; Benjafield AV; Sinha S; Kaye L; Zar HJ; Vuong V; Tellez D; Gondalia R; Rice MB; Nunez CM; Wedzicha JA; Malhotra A
    JAMA Netw Open; 2023 Dec; 6(12):e2346598. PubMed ID: 38060225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019.
    Safiri S; Carson-Chahhoud K; Noori M; Nejadghaderi SA; Sullman MJM; Ahmadian Heris J; Ansarin K; Mansournia MA; Collins GS; Kolahi AA; Kaufman JS
    BMJ; 2022 Jul; 378():e069679. PubMed ID: 35896191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of chronic obstructive pulmonary disease in rural women of Tamilnadu: implications for refining disease burden assessments attributable to household biomass combustion.
    Johnson P; Balakrishnan K; Ramaswamy P; Ghosh S; Sadhasivam M; Abirami O; Sathiasekaran BW; Smith KR; Thanasekaraan V; Subhashini AS
    Glob Health Action; 2011; 4():7226. PubMed ID: 22065945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Risk Factor Collaborators
    Lancet; 2018 Nov; 392(10159):1923-1994. PubMed ID: 30496105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.